First government panels of experts tell us that women should refrain from doing at-home breast exams and should postpone mammograms. Then we were told that pap smears don’t need to be done yearly. Now the elderly are being prohibited from getting swine flu vaccines.
Two months after H1N1 flu vaccine was first distributed to public health districts around the country, people 65 and older with serious medical conditions still can’t get vaccinated.
Anter’s doctors at Stanford University Hospital, where he received his transplant, tell him he has a compromised immune system and “the H1N1 flu could do me in.”
He takes at least nine prescription medications daily to stay alive.
“But when I try to get a shot, I’m told I’m too old ” he said as he sat in the study of his Peccole Ranch home.
“I feel that they see me and other older people as garbage and are just waiting for the trucks to come pick us up,” Anter said.
“I served my country. I enlisted during the Korean War. You don’t treat people this way just because they’re older.”
If we’re short on vaccines, we need to triage who gets vaccinated and who doesn’t. But we’ve known about swine flu for over a year.
So for me, the question is — why is the world’s superpower running out of flu vaccine — again? (Remember 2002 and 2004 and the flu vaccine shortages?) Other than the fact that inefficient government bureaucrats are controlling the supply.
The problem starts with regulation. Back in 1999, the Food and Drug Administration got a black eye after two children died from a recently approved diarrhea vaccine. The agency chose to bolster public confidence by cracking down on vaccine manufacturers. It used a new regulatory approach to ratchet up regulations, shut down plants and impose fines.
In October 2000, the FDA levied an extraordinary $30 million fine against Wyeth-Ayerst for manufacturing problems, though the government agency admitted it never found contaminated products. Several months later, citing business reasons, Wyeth got out of the market for tetanus products, leaving just one manufacturer. Wyeth and Baxter also both got out of vaccines for diphtheria, tetanus and pertussis (DTP). Their exits created major shortages.
Approval-process costs have also climbed as the FDA increases its demands. Vaccine makers used to be allowed to perform their tests with hundreds of patients, but today they need tens of thousands. The FDA’s normal approval process takes six or seven years.
Demanding higher safety is reasonable, but the problem is that public officials refuse to pay for it. Thanks to a Clinton-era program, the CDC has socialized the market and currently buys more than half of all the vaccines in the country. The agency uses its buying clout and power over future vaccine recommendations to keep prices low. In many cases, the CDC pays less than half of what the private sector pays. (emphasis added)
And this is happening without the government controlling health care for us. Any bets as to what happens when it does?

Leave a passing comment »